UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 2, 2005
AMERICAN PHARMACEUTICAL PARTNERS, INC.
(Exact name of Registrant as Specified in its Charter)
| | | | |
| Delaware | | 0-33407 | | 68-0389419 |
(State or Other Jurisdiction
of Incorporation) | | (Commission File
Number) | | (IRS Employer
Identification No.) |
| |
| 1501 East Woodfield Road, Suite 300 East; Schaumburg, IL | | 60173-5837 |
| (Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (847) 969-2700
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 1.01 | ENTRY INTO A MATERIAL AGREEMENT |
On August 2, 2005, we finalized an amendment to our existing credit facility which increased our unsecured revolving credit facility to $150 million, extended the term by one-year and made certain reductions to the margins for Eurodollar Rate Loans and future commitment fees.
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
| | |
Exhibit No.
| | Description
|
| |
| 10.25 | | Total Commitment Increase Agreement and First Amendment to Credit Agreement, dated August 2, 2005 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
| | | | | AMERICAN PHARMACEUTICAL PARTNERS, INC. |
| | | |
| Date: August 8, 2005 | | | | By: | | /s/Mark Van Ausdal |
| | | | | | | | | Mark Van Ausdal |
| | | | | | | | | Vice President and General Counsel |
EXHIBIT INDEX
| | |
Exhibit No.
| | Description
|
| |
| 10.25 | | Total Commitment Increase Agreement and First Amendment to Credit Agreement, dated August 2, 2005 |
